Wall Street Bets Big on Cyclicals for 2026: Banks, Industrials in Focus
Strategists expect banks, industrials, and retailers to outperform in 2026 as Fed rate cuts and economic growth support cyclical sectors. Here's where to look.
538 articles found for "tax"
Bitcoin Slides Below $88K as Record $23.6 Billion Options Expiry Looms
Bitcoin dropped below $88,000 as traders brace for the largest single-day options expiry in crypto history. The Fear & Greed Index signals extreme fear.
Holiday Week Preview: Markets Brace for Thin Trading as 2025 Winds Down
Markets face a holiday-shortened week with light volumes and limited catalysts. Here's what investors should watch as 2025 trading winds down.
The Santa Claus Rally: Why Wall Street Isn't Feeling the Holiday Spirit
The S&P 500 and Nasdaq are negative for December as the Santa Claus rally period approaches. Here's what historical data says about year-end trading.
Global ETF Industry Hits $19.44 Trillion as Flows Shatter All Records
Global ETF assets reach $19.44 trillion with record $2.04 trillion in annual inflows. The industry has grown 31% in 2025 alone.
The $7.1 Trillion Triple Witching: Inside the Largest Options Expiration in Market History
More than $7.1 trillion in options expired on Friday's triple witching—the largest in market history. Here's what happened and what it means for investors.
Trump Strikes Drug Pricing Deals With 9 Pharma Giants: What It Means for Your Portfolio
President Trump announces Most Favored Nation drug pricing deals with 9 major pharma companies. In exchange for price cuts, drugmakers get tariff exemptions.
FedEx Beats Expectations and Confirms Freight Spinoff on Track for June 2026
FedEx reports Q2 earnings beat with 19% EPS growth as freight spinoff preparations advance. Stock rises on raised guidance despite MD-11 fleet headwinds.
Nike Crashes 10% as China Collapse Overshadows Earnings Beat
Nike shares plunge after Q2 FY26 earnings despite beating estimates. China revenue drops 17% while tariffs threaten margins. Is the turnaround story dead?
Pfizer's 2026 Outlook Disappoints: COVID Hangover Continues to Drag on Growth
Pfizer's 2026 outlook falls short of Wall Street estimates as COVID-19 product sales decline by $1.5 billion. Here's what the guidance means for pharma investors.
Tesla Insider Sells $25 Million as Stock Approaches $460: What Kimbal Musk Knows
Elon Musk's brother Kimbal sold $25 million in Tesla shares as the stock approaches $460. Here's what insider selling signals about Tesla's current valuation.
The Fed Just Signaled a January Pause: What It Means for Your Portfolio in 2026
The Federal Reserve cut rates for the third time but signaled a potential January pause. With only two cuts expected in 2026, here's how to position your portfolio.